A future approach to measuring relative skin sensitising potency: A proposal

Journal of Applied Toxicology

Volumn 26, Issue 4, 2006, Pages 341-350

  Jowsey, Ian R ^a   Basketter, David A ^a   Westmoreland, Carl ^a   Kimber, Ian ^b  

^a UNILEVER RESEARCH   (United Kingdom)

^b JEALOTT S HILL INTERNATIONAL RESEARCH CENTRE   (United Kingdom)

Author keywords

Allergy; In silico; In vitro; Sensitisation; Skin

Indexed keywords

HAPTEN;

ARTICLE; COMPUTER MODEL; LOCAL LYMPH NODE ASSAY; LYMPHOCYTE PROLIFERATION; PRIORITY JOURNAL; PROTEIN BINDING; RISK ASSESSMENT; SCORING SYSTEM; SKIN SENSITIZATION; STRUCTURE ACTIVITY RELATION; T LYMPHOCYTE;

ANIMAL TESTING ALTERNATIVES; ANIMALS; ANTIGEN-PRESENTING CELLS; CELL PROLIFERATION; CELLS, CULTURED; DERMATITIS, ALLERGIC CONTACT; ENDPOINT DETERMINATION; HAPTENS; HUMANS; LOCAL LYMPH NODE ASSAY; LYMPH NODES; MICE; OLIGOPEPTIDES; PROTEIN BINDING; REPRODUCIBILITY OF RESULTS; RISK ASSESSMENT; SKIN; T-LYMPHOCYTES;

ANIMALIA;

EID: 33745996629     PISSN: 0260437X     EISSN: 10991263     Source Type: Journal    
DOI: 10.1002/jat.1146     Document Type: Article

References (53)

1. Aiba S, Manome H, Yoshino Y, Tagami H. 2000. In vitro treatment of human transforming growth factor-beta1-treated monocyte-derived dendritic cells with haptens can induce the phenotypic and functional changes similar to epidermal Langerhans cells in the initiation phase of allergic contact sensitivity reaction. Immunology 101: 68-75.
2. Aiba S, Terunuma A, Manome H, Tagami H. 1997. Dendritic cells differently respond to haptens and irritants by their production of cytokines and expression of co-stimulatory molecules. Eur. J. Immunol. 27: 3031-3038.
3. Ashikaga T, Hoya M, Itagaki H, Katsumura Y, Aiba S. 2002. Evaluation of CD86 expression and MHC class 11 molecule internalization in THP-1 human monocyte cells as predictive endpoints for contact sensitizers. Toxicol. In Vitro 16: 711-716.
4. Azam P, Peiffer J-L, Chamousset D, Tissier MH, Bonnet P-A, Vian L, Fahre I, Ourlin J-C. 2005. The cytokine-dependent MUTZ-3 cell line as an in vitro model for the screening of contact sensitizers. Toxicol. Appl. Pharmacol. in press.
5. Barratt MD, Basketter DA. 1992. Possible origin of the skin sensitization potential of isoeugenol and related compounds. (I). Preliminary studies of potential reaction mechanisms. Contact Dermatitis 27: 98-104.
6. Basketter DA. 1992. Skin sensitization to cinnamic alcohol: the role of skin metabolism. Acta Derm. Venereol. 72: 264-265.
7. Basketter DA, Balikie L, Dearman RJ, Kimber I, Ryan CA, Gerberick GF, Harvey P, Evans P, White IR, Rycroft RJ. 2000. Use of the local lymph node assay for the estimation of relative contact allergenic potency. Contact Dermatitis 42: 344-348.
8. Basketter DA, Evans P, Fielder RJ, Gerberick GF, Dearman RJ, Kimber I. 2002. Local lymph node assay - validation, conduct and use in practice. Food Chem. Toxicol. 40: 593-598.
9. Basketter DA, Gerberick GF, Kimber I. 2001. Measurement of allergenic potency using the local lymph node assay. Trends Pharmacol. Sci. 22: 264-265.
10. Chapuis F. Rosenzwajg M, Yagello M, Ekman M, Biberfeld P, Gluckman JC. 1997. Differentiation of human dendritic cells from monocytes in vitro. Eur. J. Immunol. 27: 431-441.
11. Coutant KD, Ulrich P, Thomas H, Cordier A, Brugerolle de Fraissinette A. 1999. Early changes in murine epidermal cell phenotype by contact sensitizers. Toxicol. Sci. 48: 74-81.
12. Cumberbatch M, Dearman RJ, Antonopoulos C, Groves RW, Kimber I. 2001. Interleukin (IL)-18 induces Langerhans cell migration by a tumour necrosis factor-alpha- and IL-1beta-dependent mechanism. Immunology 102: 323-330.
13. Cumberbatch M, Dearman RJ, Kimber I. 1997. Langerhans cells require signals from both tumour necrosis factor-alpha and interleukin-1 beta for migration. Immunology 92: 388-395.
14. Dean JH, Twerdok LE, Tice RR, Sailstad DM, Hattan DG, Stokes WS. 2001. ICCVAM evaluation of the murine local lymph node assay. Conclusions and recommendations of an independent scientific peer review panel. Regul. Toxicol. Pharmacol. 34: 258-273.
15. Dearman RJ, Hilton J, Evans P, Harvey P, Basketter DA, Kimber I. 1998. Temporal stability of local lymph node assay responses to hexyl cinnamic aldehyde. J. Appl. Toxicol. 18: 281-284.
16. Degwert J, Steckel F, Hoppe U, Kligman LH. 1997. In vitro model for contact sensitization: I. Stimulatory capacities of human blood-derived dendritic cells and their phenotypical alterations in the presence of contact sensitizers. Toxicol. In Vitro 11: 613-618.
17. Dupuis G, Benezra C. 1982. Allergic Contact Dermatitis to Simple Chemicals. Marcel Dekker: New York and Basel.
18. Enk AH, Katz SI. 1992. Early molecular events in the induction phase of contact sensitivity. Proc. Natl Acad. Sci. USA 89: 1398-1402.
19. Felter SP, Ryan CA, Basketter DA, Gilmour NJ, Gerberick GF. 2003. Application of the risk assessment paradigm to the induction of allergic contact dermatitis. Regul. Toxicol. Pharmacol. 37: 1-10.
20. Gerberick GF, House RV, Fletcher ER, Ryan CA. 1992. Examination of the local lymph node assay for use in contact sensitization risk assessment. Fundam. Appl. Toxicol. 19: 438-445.
21. Gerberick GF, Robinson MK, Ryan CA, Dearman RJ, Kimber I, Basketter DA, Wright Z, Marks JG. 2001. Contact allergenic potency: correlation of human and local lymph node assay data. Am. J. Contact Dermat. 12: 156-161.
22. Gerberick GF, Vassallo JD, Bailey RE, Chaney JG, Morrall SW, Lepoittevin JP. 2004. Development of a peptide reactivity assay for screening contact allergens. Toxicol. Sci. 81: 332-343.
23. Haneke KE, Tice RR, Carson BL, Margolin BH, Stokes WS. 2001. ICCVAM evaluation of the murine local lymph node assay. Data analyses completed by the National Toxicology Program Interagency Center for the Evaluation of Alternative Toxicological Methods. Regul. Toxicol. Pharmacol. 34: 274-286.
24. Hauser C, Katz SI. 1988. Activation and expansion of hapten- and protein-specific T helper cells from nonsensitized mice. Proc. Natl Acad. Sci. USA 85: 5625-5628.
25. Hulette BA, Ryan CA, Gerberick GF. 2002. Elucidating changes in surface marker expression of dendritic cells following chemical allergen treatment. Toxicol. Appl. Pharmacol. 182: 226-233.
26. Hulette BC, Ryan CA, Gildea LA, Gerberick GF. 2005. Relationship of CD86 surface marker expression and cytotoxicity on dendritic cells exposed to chemical allergen. Toxicol. Appl. Pharmacol. 209: 159-166.
27. Kimber I, Basketter DA. 1992. The murine local lymph node assay: a commentary on collaborative studies and new directions. Food Chem. Toxicol. 30: 165-169.
28. Kimber I, Basketter DA. 1997. Contact sensitization: a new approach to risk assessment Human Ecol. Risk Assess. 3: 385-395.
29. Kimber I, Basketter DA, Butler M, Gamer A, Garrigue JL, Gerberick GF, Newsome C, Steiling W, Vohr HW. 2003. Classification of contact allergens according to potency: proposals. Food Chem. Toxicol. 41: 1799-1809.
30. Kimber I, Cumberbatch M. 1992. Dendritic cells and cutaneous immune responses to chemical allergens. Toxicol. Appl. Pharmacol. 117: 137-146.
31. Kimber I, Dearman RJ. 1991. Investigation of lymph node cell proliferation as a possible immunological correlate of contact sensitizing potential. Food Chem. Toxicol. 29: 125-129.
32. Kimber I, Dearman RJ, Basketter DA, Ryan CA. Gerberick GF. 2002. The local lymph node assay: past, present and future. Contact Dermatitis 47: 315-328.
33. Kimber I, Pichowski JS, Betts CJ, Cumberbatch M, Basketter DA, Dearman RJ. 2001. Alternative approaches to the identification and characterization of chemical allergens. Toxicol. In Vitro 15: 307-312.
34. Krasteva M, Peguet-Navarro J. Moulon C, Courtellemont P, Redziniak G, Schmitt D. 1996. In vitro primary sensitization of hapten-specific T cells by cultured human epidermal Langerhans cells - a screening predictive assay for contact sensitizers. Clin. Exp. Allergy 26: 563-570.
35. Maurer T, Arthur A, Bentley P. 1994. Guinea-pig contact sensitization assays. Toxicology 93: 47-54.
36. Moulon C, Peguet-Navarro J, Courtellemont P, Redziniak G, Schmitt D. 1993. In vitro primary sensitization and restimulation of hapten-specific T cells by fresh and cultured human epidermal Langerhans cells. Immunology 80: 373-379.
37. Patlewicz GY, Basketter DA, Pease CK, Wilson K, Wright ZM, Roberts DW, Bernard G, Arnau EG, Lepoittevin JP. 2004. Further evaluation of quantitative structure-activity relationship models for the prediction of the skin sensitization potency of selected fragrance allergens. Contact Dermatitis 50: 91-97.
38. Patlewicz G, Basketter DA, Smith CK, Hotchkiss SA, Roberts DW. 2001. Skin-sensitization structure-activity relationships for aldehydes. Contact Dermatitis 44: 331-336.
39. Patlewicz GY, Wright ZM, Basketter DA, Pease CK, Lepoittevin JP, Arnau EG. 2002. Structure-activity relationships for selected fragrance allergens. Contact Dermatitis 47: 219-226.
40. Pichowski JS, Cumberbatch M, Dearman, Basketter DA, Kimber I. 2000. Investigation of induced changes in interleukin 1beta mRNA expression by cultured human dendritic cells as an in vitro approach to skin sensitization testing. Toxicol. In Vitro 14: 351-360.
41. Pichowski JS, Cumberbatch M, Dearman RJ, Basketter DA, Kimber I. 2001. Allergen-induced changes in interleukin 1 beta (IL-1 beta) mRNA expression by human blood-derived dendritic cells: interindividual differences and relevance for sensitization testing. J. Appl. Toxicol. 21: 115-121.
42. Potts RO, Guy RH. 1992. Predicting skin permeability. Pharm. Res. 9: 663-669.
43. Reutter K, Jager D, Degwert J, Hoppe U. 1997. In vitro model for contact sensitization: II. Induction of IL-1β mRNA in human blood-derived dendritic cells by contact sensitizers. Toxicol. in Vitro 11: 619-626.
44. Roberts DW, Basketter DA. 2000. Quantitative structure-activity relationships: sulfonate esters in the local lymph node assay. Contact Dermatitis 42: 154-161.
45. Rougier N, Redziniak G, Mougin D, Schmitt D, Vincent C. 2000. In vitro evaluation of the sensitization potential of weak contact allergens using Langerhans-like dendritic cells and autologous T cells. Toxicology 145: 73-82.
46. Rustemeyer T, Preuss M, von Blomberg BM, Das PK, Scheper RJ. 2003. Comparison of two in vitro dendritic cell maturation models for screening contact sensitizers using a panel of methacrylates. Exp. Dermatol. 12: 682-691.
47. Sailstad DM, Hattan D, Hill RN, Stokes WS. 2001. ICCVAM evaluation of the murine local lymph node assay. The ICCVAM review process. Regul. Toxicol. Pharmacol. 34: 249-257.
48. Sallusto F, Lanzavecchia A. 1994. Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/ macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha. J. Evol. Med. 179: 1109-1118.
49. Smith CK, Hotchkiss SAM. 2001. Allergic Contact Dermatitis-Chemical and Metabolic Mechanisms. Taylor & Francis: UK.
50. Steiling W, Basketter D, Berthold K, Butler M, Garrigue JL, Kimber I, Lea L, Newsome C, Roggeband R, Stropp G, Waterman S, Wiemann C. 2001. Skin sensitisation testing -new perspectives and recommendations. Food Chem. Toxicol. 39: 293-301.
51. Tuschl H, Kovac R. 2001. Langerhans cells and immature dendritic cells as model systems for screening of skin sensitizers. Toxicol. In Vitro 15: 327-331.
52. Warbrick EV, Dearman RJ, Lea LJ, Basketter DA, Kimber I. 1999. Local lymph node assay responses to paraphenylenediamine: intra- and inter-laboratory evaluations. J. Appl. Toxicol. 19: 255-260.
53. Yoshida Y, Sakaguchi H, Ito Y, Okuda M, Suzuki H. 2003. Evaluation of the skin sensitization potential of chemicals using expression of co-stimulatory molecules, CD54 and CD86, on the naive THP-1 cell line. Toxicol. In Vitro 17: 221-228.